Mobile Technology Is Useful in Collecting Patient-Reported Outcomes
The researchers also developed novel emoji PRO scales and associations between PROs and wearable data.
The researchers also developed novel emoji PRO scales and associations between PROs and wearable data.
The U.S. Food and Drug Administration has approved brentuximab vedotin for the treatment of adult patients with pcALCL or CD30-expressing mycosis fungoides who have received prior systemic therapy.
The FDA has granted alectinib (ALECENSA) accelerated approval for the treatment of patients with non-small cell lung cancer.
Using a genotype-guided dose of fluoropyrimidine in DPYD*2A variant allele carriers significantly reduced grade 3 or higher toxicities.
As of 2012 in the U.S. there were 14 million cancer survivors, a number that is expected to grow to 18 million by 2022.
The FDA announced approval of CYRAMZA (ramucirumab) for use in combination with FOLFIRI for metastatic colorectal cancer.
POMALYST for relapsed/refractory multiple myeloma has met its accelerated approval requirements.
FDA has granted approval for Somatuline (lanreotide; Ipsen) injection 120 mg for gastroenteropancreatic neuroendocrine tumors.